Navigation Links
Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
Date:10/1/2009

n number to listen to the recording is (888) 286 8010 or (617) 801 6888. The replay access code is 35358896. The call will be archived on the Company's website for at least 90 days.

About Misonix:

Misonix, Inc. (Nasdaq: MSON) designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and
'/>"/>

SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Spherix Reports Second Quarter Earnings
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... AMSTERDAM, December 16 Today, Avantium ... Executive Officer of its pharmaceutical,business. Gunnar Staaf ... and Eli Lilly & Company, in a ... is an important step in Avantium,s plan ... to create a,stand-alone pharmaceutical company based on ...
(Date:12/16/2009)... Senate Vote Against Lower Prescription Drug Prices ... Senate on Tuesday night rejected an amendment to ... would help make prescription drugs more affordable by ... lower priced drugs from abroad. The bipartisan ... Dorgan, Snowe, McCain, Grassley and Stabenow, would have ...
(Date:12/16/2009)... Calif., Dec. 16 Frost & ... Bujnoch, looks forward to speaking at the ... taking place on January 9, 2010 in ... the emerging market of consumer-based digital health ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, Bujnoch ...
Breaking Medicine Technology:Avantium Appoints Gunnar Staaf as CEO Pharma 2AARP Illinois Key Vote News Alert 2Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit 2Optimization and Scale up of a Hydrodynamically Limited Anti Solvent Crystallization Process 3A From Lab to Plant 13541 1Optimization and Scale up of a Hydrodynamically Limited Anti Solvent Crystallization Process 3A From Lab to Plant 13541 2TrueVision Teams with Ophthalmologists to Help Cure World Blindness for Treatable Cataracts Debut of 3D Training Video for Manual Small Incision C 54393 1TrueVision Teams with Ophthalmologists to Help Cure World Blindness for Treatable Cataracts Debut of 3D Training Video for Manual Small Incision C 54393 2TrueVision Teams with Ophthalmologists to Help Cure World Blindness for Treatable Cataracts Debut of 3D Training Video for Manual Small Incision C 54393 3TrueVision Teams with Ophthalmologists to Help Cure World Blindness for Treatable Cataracts Debut of 3D Training Video for Manual Small Incision C 54393 4Medco Health Solutions United Drug Announce U K Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions 3B Innov 54388 1Medco Health Solutions United Drug Announce U K Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions 3B Innov 54388 2Medco Health Solutions United Drug Announce U K Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions 3B Innov 54388 3
... Product Candidate in Clinical Trials, SEATTLE, Sept. ... enrolling patients in a Phase 1/Phase 2 study ... use during,ophthalmologic surgery. At least 60 patients undergoing ... enrollment in the,study., "With the initiation of ...
... 8 FluoroPharma, Inc. announced today that,Dr. ... Advisor,will report on two preclinical studies demonstrating ... molecular imaging agents for detection,of Alzheimer,s disease ... Molecular,Imaging Congress, in Nice, France on September ...
Other Medicine Technology:Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302 2FluoroPharma, Inc. to Report Preclinical Data on Alzheimer's Disease and Prostate Cancer PET Imaging Agents 2FluoroPharma, Inc. to Report Preclinical Data on Alzheimer's Disease and Prostate Cancer PET Imaging Agents 3
(Date:12/16/2009)... Kayentis, the global leader of Digital Pen and Paper technology ... for clinical trials, today announced that it is ranked among ... 500 - EMEA 2009. , ... ... integrated software solutions for the capture, digitalization and management of ...
(Date:12/16/2009)... marketing campaign , ... Englewood, CO ... Genetown™ Hotbed Campaign as its largest yearly promotion for ... MassBio and showcases 37 Massachusetts companies across biotechnology, ... brand on an electronic and printed map that ...
(Date:12/16/2009)... uninsured, government report finds , , WEDNESDAY, Dec. 16 (HealthDay ... year, 45.4 million Americans of all ages -- or ... insurance, according to new National Health Interview Survey statistics ... people of all ages had been uninsured for at ... and 31.9 million (10.6 percent) had been uninsured for ...
(Date:12/16/2009)... -- Shoppers like knowing if their salad is ... grocers have found it burdensome to implement the ... them to provide the information at point of ... for easily making grocery and produce signs ... require retailers of unprocessed fruits, vegetables and other ...
(Date:12/16/2009)... Medical travel facilitator Companion Global Healthcare ... Rico into its network of international hospitals that ... those at mainland U.S. facilities. ,, The announcement ... assistance and preferred pricing for its individual clients ... either HIMA San Pablo Bayamon or HIMA San ...
Breaking Medicine News(10 mins):Health News:With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 2Health News:Thriving Bioscience Region Leaves Its Mark 2Health News:Over 45 Million Americans Now Lack Health Insurance 2Health News:New Website Helps Grocers Comply With COOL Laws 2Health News:Hospitals in Puerto Rico Join Companion Global Healthcare's Network 2
... associated with any biological or adverse health effects, according ... risks from mobile telephone technology. , The Mobile Telecommunications ... September 12 as part of its 2007 Report. , ... Emeritus Professor of Physics at The University of Nottingham, ...
... Pink Savings Cards Give Tanger Shoppers the Chance to Help ... Saving Money on Their Purchases, GREENSBORO, N.C., Sept. 12 ... at Tanger Outlet Centers. Tanger is celebrating its,14th anniversary in ... Shoppers can join Tanger in its effort to save lives ...
... to the Public, ATLANTA, Sept. 12 ... investment company is about to launch a new ... will bring,professional-grade physical therapy and sports rehabilitation services ... http://www.newscom.com/cgi-bin/prnh/20070912/DCW010LOGO ) AMB Group, LLC, today ...
... Inc., a,pioneer in health and condition (disease) management, ... Synergy Personal Health,Management program at DMAA,s Disease Management ... at Caesar,s Palace in Las,Vegas. With the ... to stay,informed of the best practices, latest technologies ...
... Liberty State Park to celebrate and press for ... JERSEY CITY, N.J., Sept. 12 , What: The joint New Jersey/New York ... centerpiece of more than 50 celebratory and advocacy ... of Americans who are in long-term recovery from addiction to ...
... grant and an Ontario Early Researcher Award, Prof. Yu ... http://amnl.mie.utoronto.ca ) at the University of Toronto (U of ... of zebrafish embryos. , Based on computer vision ... of immobilizing a large number of zebrafish embryos into ...
Other Medicine News:Health News:New report on mobile phone research published 2Health News:Photo: Tanger Outlet Center Shoppers Nationwide can Choose Pink to Fight Breast Cancer 2Health News:Atlanta Falcons Physical Therapy Centers Set to Launch This Fall 2Health News:Atlanta Falcons Physical Therapy Centers Set to Launch This Fall 3Health News:Health Integrated to Showcase Synergy Personal Health Management(R) at DMAA Conference 2
... The Volk G-1 trabeculum provides the highest magnification ... for viewing and treating the trabecular meshwork. ... the anterior chamber angle while the central portion ... the posterior pole for signs of glaucoma and ...
... Volks Disposable SSV® Vitrectomy Lenses are a ... to enable a view of a particular region ... contact lens element weighs less than 1 gram ... with the typical shape of a human cornea. ...
... 30° Prism are designed for ... recommended for tractional retinal detachments ... retinal detachment. They can be ... other midperipheral laser applications. Direct ...
... The 30° Prism is ... pathologies and are recommended ... (PDR, BRVO etc.) and ... can be used for ...
Medicine Products: